Cell MedX Corp.CMXC,  (the “Company”) announced today that it has completed the acquisition of a proprietary technology for the treatment of diabetes and related ailments (the “Technology”) from the inventors of the Technology, Jean Arnett and Bradley Hargreaves. 545 more words